Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Shikata

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
Cancer|May 1, 1987
Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. A study with a combined preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracilH Hanaue, T Kurosawa, Y Kitano, et al.
Nihon Gan Chiryo Gakkai Shi|October 20, 1987
[A study of the diagnosis of breast cancer]T Asagoe, H Hanaue, T Kurosawa, et al.
The Tokai Journal of Experimental and Clinical Medicine|May 1, 1987
Effects of biological response modifier on thoracic duct lymphocytes in recurrent gastric cancer. Evaluation of OK-432, a hemolytic streptococcus preparationH Hanaue, D Y Kim, M Kubota, et al.
The Tokai Journal of Experimental and Clinical Medicine|November 1, 1987
Hemolytic streptococcus preparation OK-432; beneficial adjuvant therapy in recurrent gastric carcinomaH Hanaue, D Y Kim, T Machimura, et al.
The Tokai Journal of Experimental and Clinical Medicine|September 1, 1987
Effects of oral administration of streptococcal preparation OK-432 on thoracic duct lymphocytesH Hanaue, D Y Kim, T Machimura, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
Cancer|May 1, 1987
Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. A study with a combined preparation of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracilH Hanaue, T Kurosawa, Y Kitano, et al.
Nihon Gan Chiryo Gakkai Shi|October 20, 1987
[A study of the diagnosis of breast cancer]T Asagoe, H Hanaue, T Kurosawa, et al.
The Tokai Journal of Experimental and Clinical Medicine|May 1, 1987
Effects of biological response modifier on thoracic duct lymphocytes in recurrent gastric cancer. Evaluation of OK-432, a hemolytic streptococcus preparationH Hanaue, D Y Kim, M Kubota, et al.
The Tokai Journal of Experimental and Clinical Medicine|November 1, 1987
Hemolytic streptococcus preparation OK-432; beneficial adjuvant therapy in recurrent gastric carcinomaH Hanaue, D Y Kim, T Machimura, et al.
The Tokai Journal of Experimental and Clinical Medicine|September 1, 1987
Effects of oral administration of streptococcal preparation OK-432 on thoracic duct lymphocytesH Hanaue, D Y Kim, T Machimura, et al.
Pageof 15